Related Experiment Video

Updated: Aug 24, 2026

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
06:39

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Published on: October 3, 2018

Pediatric myelodysplastic syndromes

Michael E Rytting1

  • 1Division of Pediatrics, MD Anderson Cancer Center, 1515 Holcombe Boulevard, Box 87, Houston, TX 77030, USA. mrytting@mdanderson.org

Current Hematology Reports
|April 17, 2004
PubMed

Insights

Pediatric myelodysplastic syndromes (MDS) are clonal disorders affecting blood cell production. Current pediatric classification systems are debated, but new insights and therapies offer hope for children with MDS.

Area of Science:

  • Pediatric Hematology
  • Oncology
  • Genetics

Background:

  • Myelodysplastic syndromes (MDS) in children are clonal hematopoietic disorders.
  • These disorders lead to ineffective blood cell production, low blood counts, and an increased risk of acute myelogenous leukemia.
  • Pediatric MDS is often linked to other genetic conditions.

Purpose of the Study:

  • To review the current landscape of pediatric myelodysplastic syndromes.
  • To highlight the challenges in pediatric MDS classification compared to adult systems.
  • To discuss the potential impact of emerging biological insights and therapies on pediatric MDS treatment.

Main Methods:

  • Literature review of pediatric myelodysplastic syndromes.
  • Analysis of existing and proposed pediatric classification systems.
  • Synthesis of current research on MDS biology and novel therapeutic approaches.

Main Results:

  • Established adult MDS classification systems are not universally accepted in pediatrics.
  • Several pediatric-specific classification systems have been proposed but await widespread clinical adoption.
  • Advances in understanding MDS biology and adult treatment strategies are paving the way for pediatric advancements.

Conclusions:

  • Accurate classification remains a challenge in pediatric myelodysplastic syndromes.
  • Translating adult treatment innovations to pediatric care holds significant promise.
  • Further research and consensus on classification are needed to optimize care for children with MDS.

More Related Videos

Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation12:05

Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation

Published on: November 3, 2018

Identifying Bone Marrow Microenvironmental Populations in Myelodysplastic Syndrome and Acute Myeloid Leukemia06:33

Identifying Bone Marrow Microenvironmental Populations in Myelodysplastic Syndrome and Acute Myeloid Leukemia

Published on: November 10, 2023

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
Alternative RNA Splicing02:18

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...